Non-regulatory news

Oslo, 10 June 2026 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) is pleased to host a presentation with trading update Friday, 26 June 2026. Observe Medical invites investors, analysts, and other stakeholders to the presentation which will take place virtually Friday 26 June 2026, at 10:00 CEST, and streamed via webcast at…

Oslo, 26 May 2026 – Observe Medical ASA (the "Company" or "Observe Medical") is pleased to announce that an Abstract with in vitro clinical data related to the Company’s UnoMeter[TM] Safeti[TM] Max has been accepted for presentation and publication by the International Continence Society. The accepted Abstract presents findings from in vitro studies evaluating the…

Oslo, 25 March 2026 – Observe Medical ASA (the "Company" or "Observe Medical") announces that its journey into the strategically important Indian market has reached a new level through the signing of an exclusive distribution agreement with a leading local partner. This replaces the previously announced LOI. The partner is a historical distributor of UnoMeter™ and…

Oslo, 25 March 2026. With reference to today's webcast, please find enclosed the presentation. Key topics: · 80% growth in quarterly sales LTM · Commercial launch of UnoMeter™ Safeti Max · Extended product offering to our distributors, capitalizing on the UnoMeter brand position · Sales in 46 countries  · Current addressable market value grown from…

Oslo, 4 March, 2026 – Observe Medical ASA (the "Company" or "Observe Medical") announces initiatives to reduce complexity and cost to invest further in growth. Innovation Norway financing The Company has received a NOK 15 million loan from Innovation Norway. The loan has been disbursed and strengthens the Company’s cash position and supports continued development of…

Oslo, 11 February 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces entry into the Indian market with LOI signed with strong local partner and first order received. India represents one of the largest and fastest-growing healthcare markets worldwide and is projected to grow at a compound annual growth rate (CAGR) of 15–18%,…

Oslo, 12 December 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces expansion of portfolio, progress on commercial journey and in the development of UnoMeter™ Safeti™ Max. The Company is launching an extension of its portfolio of products within the category of Urological Drainage. The launch includes 3 new products: a front mounted…

Oslo, 7 October 2025. With reference to today's webcast, please find enclosed the presentation, also made available at https://observemedical.com/. A recording of the presentation is also available at: Hegnar Media – Observe Medical Trading update 7 october 2025 (https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20251007_1) For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com Johan Fagerli, CFO…

Oslo, 25 September 2025 – Observe Medical ASA (the "Company" or "Observe Medical") announces further progress in the Italian market. The Company’s distributor in Italy has secured a public tender to supply UnoMeter™ products into the largest region in Italy, corresponding to an estimated olume of approximately 240,000 units annually for a period of three…

Oslo, 19 September 2025 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host a presentation with trading update Tuesday, 7 October 2025. Observe Medical invites investors, analysts, and other stakeholders to the presentation which will take place virtually Tuesday 7 October 2025, at 09:00 CET, and streamed via webcast at the…

Oslo, September 11, 2025 – Observe Medical ("the Company" or "Observe Medical") has initiated activities in 2 additional South American markets, Brazil and Colombia, representing a combined population of approximately 260 million. With this expansion, the Company’s UnoMeter™ branded product family is now represented in 43 countries worldwide. Jørgen Mann, CEO of Observe Medical, commented: "Our…

Oslo, August 21, 2025 – Observe Medical ("the Company" or "Observe Medical") has received additional orders from the distributor in Switzerland after several successful hospital conversions and also receives first orders from new distributor in Slovenia after hospital product evaluations. Jørgen Mann, CEO of Observe Medical, commented: " The Swiss market is a very critical market in…

Oslo, July 11, 2025 – Observe Medical (“the Company” or “Observe Medical”) is pleased to announce that it has received first orders for UnoMeter™ Safeti™ Plus from distributors covering Argentina and the seven Central American countries. This comes in addition to a previous order already received from Chile. These markets together represent approximately 75% of…

Oslo, June 24, 2025 – Observe Medical ("the Company" or "Observe Medical") is pleased to announce that UnoMeter[TM] Safeti[TM] Plus has been appointed exclusive winner of the tender in the largest region in Sweden, representing approximately 20% of the total Swedish market. In Finland UnoMeter[TM] Safeti[TM] has been awarded the tender for Helsinki and Tampere which…

Oslo, April 28, 2025 – Observe Medical ("the Company" or "Observe Medical") is happy to announce that UnoMeter[TM] Safeti[TM] Plus is now accepted by NHS to be included on the national listing for England. Also Observe Medical has received first order of UnoMeter[TM] Safeti[TM] Plus from Portugal and the journey to create a strategic partnership with Jiangsu…

With reference to today's webcast, please find enclosed the presentation, also made available at https://observemedical.com/. A recording of the presentation is also available at: https://sdk.companywebcast.com/sdk/player/?id=hegnarmedia_20250410_3&customBtnColor=da7038,674429 (https://eur03.safelinks.protection.outlook.com/?url=httpssdk.companywebcast.comsdkplayeridhegnarmedia_20250410_3customBtnColorda7038674429&data=0502johan.fagerliobservemedical.com95918ad22c144110968908dd66e57693139dbc03ecf246efb467a338c990a8d600638779858079459528UnknownTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ0&sdata=pG0x7hXETFnlsfcETvp0xYQ4Wlv1xEpVJkrVIwa0&reserved=0) For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com Johan Fagerli, CFO Observe Medical Mobile: +47 958 12 765 E-mail: johan.fagerli@observemedical.com About Observe Medical Observe Medical…

Oslo, 19 March 2025 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host an investor presentation with trading update Thursday, 10 April 2025, at 10:00 CET. Observe Medical invites investors, analysts, and other stakeholders to an investor presentation with trading update Thursday 10 April 2025, at 10:00 CET. The presentation will…

Oslo, 13 March, 2025 – Observe Medical ("the Company" or "Observe Medical") has received repeat orders and now first significant orders from the Nordic region where UnoMeter[™] Safeti[™] Plus historically has held a very dominating position. Historically, UnoMeter[™] Safeti[™] Plus has had a dominating market share in this region consistently exceeding 70% across most markets. The annual sales…

Oslo, 6 March, 2025 –Observe Medical ("the Company" or "Observe Medical") has received a significant repeat order from the very important Italian market that in 2021 represented almost 20 mNOK of the total UnoMeter™ annual sales. After testing UnoMeter™ Safeti™ Plus at key customers in the Italian market and subsequently received very positive feedback on…

Oslo, February 28, 2025 – Observe Medical ("the Company" or "Observe Medical") has received order from the very important UK market that in 2021 represented more than 40 mNOK of the total UnoMeter™ sales. The first significant deliveries of UnoMeter™ Safeti™ Plus to the distribution network started in January, with increasing levels in February, and the revenue…